Literature DB >> 16372264

Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis.

Prathiba Kurupati1, Boon King Teh, Gamini Kumarasinghe, Chit Laa Poh.   

Abstract

Klebsiella pneumoniae is an opportunistic pathogen which causes pneumoniae, urinary tract infections and septicemia in immunocompromised patients. Hospital outbreaks of multidrug-resistant K. pneumoniae, especially those in neonatal wards, are often caused by strains producing the extended-spectrum-beta-lactamases (ESBLs). An immunoproteome based approach was developed to identify candidate antigens of K. pneumoniae for vaccine development. Sera from patients with acute K. pneumoniae infections (n = 55) and a control group of sera from healthy individuals (n = 15) were analyzed for reactivity by Western blot against ESBL K. pneumoniae outer membrane proteins separated by 2-DE. Twenty highly immunogenic protein spots were identified by immunoproteomic analysis. The immunogenic proteins that are most frequently recognized by positive K. pneumoniae sera were OmpA, OmpK36, FepA, OmpK17, OmpW, Colicin I receptor protein and three novel proteins. Two of the vaccine candidate genes, OmpA (Struve et al. Microbiology 2003, 149, 167-176) and FepA (Lai, Y. C. et al.. Infect Immun 2001, 69, 7140-7145), have recently been shown to be essential in colonization and infection in an in vivo mouse model. Hence, these two immunogenic proteins could serve as potential vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372264     DOI: 10.1002/pmic.200500214

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  20 in total

1.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.

Authors:  Prathiba Kurupati; N P Ramachandran; Chit Laa Poh
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

Review 3.  Vaccinology in the genome era.

Authors:  C Daniela Rinaudo; John L Telford; Rino Rappuoli; Kate L Seib
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

Review 4.  Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae.

Authors:  C Hennequin; F Robin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

5.  Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.

Authors:  Xiabing Chen; Zhuofei Xu; Lu Li; Huanchun Chen; Rui Zhou
Journal:  J Microbiol       Date:  2012-12-30       Impact factor: 3.422

6.  Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity.

Authors:  Yi-Fang Liu; Jing-Jou Yan; Huan-Yao Lei; Ching-Hao Teng; Ming-Cheng Wang; Chin-Chung Tseng; Jiunn-Jong Wu
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

7.  Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.

Authors:  Urban Lundberg; Beatrice M Senn; Wolfgang Schüler; Andreas Meinke; Markus Hanner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

9.  Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.

Authors:  Erin C Hagan; Harry L T Mobley
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

10.  Immunoproteomic analysis of outer membrane proteins and extracellular proteins of Actinobacillus pleuropneumoniae JL03 serotype 3.

Authors:  Yonghong Liao; Junhua Deng; Anding Zhang; Mingguang Zhou; Yong Hu; Huanchun Chen; Meilin Jin
Journal:  BMC Microbiol       Date:  2009-08-20       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.